The low response may be due to the high desmoplastic reaction, poor tumor vascularization and the hypoxic environment present in the tumor microenvironment together with different genetic alterations, for example in KRAS and c-MYC, which prevent the activation of pathways related to IFNα and PD-L1, favoring immune suppression [92]. This evidence concerns the gene KRAS and neoplasm.